Pharmaceuticals

A new process can print multiple medications onto a single dissolvable strip, microneedle patch or other surface.

Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered over an extended time period with just one injection.

To better understand why some cancers are resistant to immunotherapy, researchers collaborated on a large-scale CRISPR cancer study.

A professor's method to "upconvert" light could make solar cells more efficient and disease-targeting nanoparticles more effective.

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients.

Exscientia has entered into a strategic drug discovery collaboration with GlaxoSmithKline.

Doxorubicin, originally daunorubicin, is the result of a simultaneous discovery event in the 1950's between researchers in France and Italy. The molecule, a well-known anti-cancer drug used for a variety of indications ranging from acute lymphocytic leukemia to breast cancer, was approved for use in the United States in 1974.